| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 659094 | 62117 | COZAAR 12.5 mg INICIO COMPRIMIDOS RECUBIERTOS CON PELICULA | COZAAR 12.5 mg INICIO COMPRIMIDOS RECUBIERTOS CON PELICULA , 7 comprimidos | 12,5 mg | 5 | 7 | 10 | 7 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62117/62117_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62117/62117_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35083 | ORGANON SALUD S.L. | 1998-06-01 | 1 | 1 | 1 | 1998-06-01 | 1998-06-01 | 1 | 2011-09-28 | View Edit Delete | ||||||||||||
| 660079 | 69376 | ARCOXIA 30 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ARCOXIA 30 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 30 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69376/69376_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69376/69376_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35083 | ORGANON SALUD S.L. | 2007-11-02 | 1 | 1 | 1 | 2007-11-05 | 2007-11-02 | 1 | 2011-09-28 | View Edit Delete | ||||||||||||
| 660088 | 05310007 | FOSAVANCE 70 MG/5.600 UI COMPRIMIDOS | FOSAVANCE 70 MG/5.600 UI COMPRIMIDOS , 4 comprimidos | 70 mg/5.600 UI | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/05310007/05310007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/05310007/05310007_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48716 | ORGANON SALUD S.L. | 2007-11-23 | 1 | 1 | 1 | 2007-11-23 | 2007-11-23 | 1 | 2011-03-21 | View Edit Delete | ||||||||||||
| 659190 | 68879 | BIOBICA 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | BIOBICA 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 50 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68879/68879_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68879/68879_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28152 | BIOWISE PHARMACEUTICALS, S.L. | 2007-06-01 | 1 | 1 | 1 | 2007-06-04 | 2007-06-01 | 1 | 2012-03-09 | View Edit Delete | ||||||||||||
| 658953 | 07387014 | ADVAGRAF 0,5 MG CAPSULAS DURAS DE LIBERACION PROLONGADA | ADVAGRAF 0,5 MG CAPSULAS DURAS DE LIBERACION PROLONGADA, 30 cápsulas | 0,5 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07387014/07387014_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07387014/07387014_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 13990 | ASTELLAS PHARMA S.A. | 2012-07-24 | 1 | 1 | 1 | 2012-07-24 | 2012-07-24 | 1 | 2023-10-24 | View Edit Delete | ||||||||||||
| 658954 | 07387017 | ADVAGRAF 1 MG CAPSULAS DURAS DE LIBERACION PROLONGADA | ADVAGRAF 1 MG CAPSULAS DURAS DE LIBERACION PROLONGADA 30 cápsulas | 1 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07387017/07387017_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07387017/07387017_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 13990 | ASTELLAS PHARMA S.A. | 2012-07-24 | 1 | 1 | 1 | 2012-07-24 | 2012-07-24 | 1 | 2023-10-24 | View Edit Delete | ||||||||||||
| 658956 | 07387019 | ADVAGRAF 1 MG CAPSULAS DURAS DE LIBERACION PROLONGADA | ADVAGRAF 1 MG CAPSULAS DURAS DE LIBERACION PROLONGADA, 60 cápsulas | 1 mg | 5 | 60 | 43 | 60 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07387019/07387019_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07387019/07387019_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 13990 | ASTELLAS PHARMA S.A. | 2012-07-24 | 1 | 1 | 1 | 2012-07-24 | 2012-07-24 | 1 | 2023-10-24 | View Edit Delete | ||||||||||||
| 658957 | 07387024 | ADVAGRAF 5 MG CAPSULAS DURAS DE LIBERACION PROLONGADA | ADVAGRAF 5 MG CAPSULAS DURAS DE LIBERACION PROLONGADA, 30 cápsulas | 5 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07387024/07387024_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07387024/07387024_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 13990 | ASTELLAS PHARMA S.A. | 2012-07-24 | 1 | 1 | 1 | 2012-07-24 | 2012-07-24 | 1 | 2023-10-24 | View Edit Delete | ||||||||||||
| 658929 | 68732 | OLANZAPINA QUALIGEN 2,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLANZAPINA QUALIGEN 2,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 2,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68732/68732_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68732/68732_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2007-04-30 | 1 | 1 | 1 | 2007-04-30 | 2007-04-30 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 658931 | 68733 | OLANZAPINA QUALIGEN 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLANZAPINA QUALIGEN 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68733/68733_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68733/68733_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2007-04-27 | 1 | 1 | 1 | 2007-04-27 | 2007-04-27 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 658932 | 68734 | OLANZAPINA QUALIGEN 7,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLANZAPINA QUALIGEN 7,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 56 comprimidos | 7,5 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68734/68734_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68734/68734_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2007-04-30 | 1 | 1 | 1 | 2007-04-30 | 2007-04-30 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 658933 | 68735 | OLANZAPINA QUALIGEN 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLANZAPINA QUALIGEN 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68735/68735_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68735/68735_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2007-04-27 | 1 | 1 | 1 | 2007-04-27 | 2007-04-27 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 658934 | 68735 | OLANZAPINA QUALIGEN 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLANZAPINA QUALIGEN 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 56 comprimidos | 10 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68735/68735_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68735/68735_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2007-04-27 | 1 | 1 | 1 | 2007-04-27 | 2007-04-27 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 659212 | 68891 | ACIDO ALENDRONICO SEMANAL QUALIGEN 70 mg COMPRIMIDOS EFG | ACIDO ALENDRONICO SEMANAL QUALIGEN 70 mg COMPRIMIDOS EFG, 4 comprimidos | 70 mg | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68891/68891_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68891/68891_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2007-06-05 | 1 | 1 | 1 | 2007-06-05 | 2007-06-05 | 0 | 2012-01-02 | View Edit Delete | ||||||||||||
| 659361 | 68990 | ARENBIL 2,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ARENBIL 2,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 2,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68990/68990_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68990/68990_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2007-06-19 | 1 | 1 | 1 | 2007-06-19 | 2007-06-19 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 659362 | 68991 | ARENBIL 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ARENBIL 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68991/68991_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68991/68991_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2007-06-19 | 1 | 1 | 1 | 2007-06-19 | 2007-06-19 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 659363 | 68992 | ARENBIL 7,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ARENBIL 7,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 56 comprimidos | 7,5 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68992/68992_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68992/68992_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2007-06-19 | 1 | 1 | 1 | 2007-06-19 | 2007-06-19 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 659364 | 68993 | ARENBIL 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ARENBIL 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68993/68993_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68993/68993_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2007-06-19 | 1 | 1 | 1 | 2007-06-19 | 2007-06-19 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 659365 | 68993 | ARENBIL 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ARENBIL 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 56 comprimidos | 10 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68993/68993_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68993/68993_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 2007-06-19 | 1 | 1 | 1 | 2007-06-19 | 2007-06-19 | 1 | 2011-05-12 | View Edit Delete | ||||||||||||
| 659182 | 06378001 | INOVELON 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | INOVELON 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 10 comprimidos | 100 mg | 5 | 10 | 10 | 10 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06378001/06378001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06378001/06378001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 34732 | EISAI FARMACÉUTICA S.A. | 2007-07-31 | 1 | 1 | 1 | 2007-07-31 | 2007-07-31 | 1 | 2011-07-20 | View Edit Delete |
Page 148 of 1035, showing 20 records out of 20697 total, starting on record 2941, ending on 2960